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Abstract
Background: This study examines the psychometric properties of the Malay version of the Montgomery-Ǻsberg
Depression Rating Scale (MADRS-BM).
Methods: A total of 150 participants with (n = 50) and without depression (n = 100) completed the self-rated
version of the Montgomery-Ǻsberg Depression Rating Scale (MADRS-S), the Malay versions of the MADRS-BM, the
Beck Depression Inventory-II (BDI-II-M), the General Health Questionnaire-12 (GHQ-12), and the Snaith-Hamilton
Pleasure Scale (SHAPS-M).
Results: With respect to dimensionality of the MADRS-BM, we obtained one factor solution. With respect to reliability,
we found that internal consistency was satisfactory. The scale demonstrated excellent parallel form reliability. The
one-week test-retest reliability was good. With respect to validity, positive correlations between the MADRS-BM,
BDI-II-M, and the GHQ and negative correlation between the MADRS-BM and SHAPS-M provide initial evidence of
MADRS-BM’s concurrent validity. After adjusting for age, gender, ethnicity, educational level, and marital status,
individuals with depression significantly reported higher MADRS-BM scores than did individuals without depression.
Hence, there is additional evidence for concurrent validity of the MADRS-BM. Cut-off score of 4 distinguished individuals
with depression from individuals without depression with a sensitivity of 78 % and a specificity of 86 %.
Conclusions: The MADRS-BM demonstrated promising psychometric properties in terms of dimensionality, reliability,
and validity that generally justifies its use in routine clinical practice in Malaysia.
Background
To study treatment efficacy, researchers often rely on the
use of clinician-rated instruments [1]. Clinician-rated
instruments like the Montgomery-Åsberg Depression
Rating Scale (MADRS) have been widely used to assess
depression [2].
The MADRS is a popular scale because of its high inter-
rater reliability and high sensitivity to detect changes in
treatment effects [2]. Due to these features, the MADRS
has been widely used in mood disorders studies [3–5].
However, the MADRS has recently received increased
scrutiny due to rising rate of unsuccessful clinical trials
[6]. As reported in the clinical trials, poor inter-rater
reliability and rater bias are two common shortcomings
associated with clinician-rated scales like the MADRS.
Due to these shortcomings, clinical assessment pertaining
to depression severity is a subject of debate [7]. The
robustness of clinical findings is also questionable [7]. To
address this research gap, the MADRS-S, a 9-item self-re-
port measure of depression, was developed [8]. Partici-
pants rate items on a 4-point Likert scale ranging from
0 (no depressive symptoms) to 3 (worst depressive symp-
toms). Possible score ranges from 0 to 27, with higher
scores indicating greater symptom severity. The
MADRS-S has been found to have a high degree of
concordance with the clinician-rated MADRS and dem-
onstrates adequate reliability (alpha = 0.84; intraclass
correlation coefficient, ICC = 0.78) [9].
Although in Malaysia, there are a few scientific attempts
devoted to validate depression scales such as the Malay
versions of the Beck Depression Index (BDI) [10], Beck
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Depression Index, Second Edition (BDI-II) [11], and the
Depression Anxiety and Stress Scales (DASS) [12]. In the
case of the Malay version of the BDI, the scale has been
validated in a depression sample [10] and has resulted two
major revisions—the authors removed four items which
have low sensitivity in identifying typical depressive symp-
toms. Therefore, identification of depressive symptoms in
psychiatric samples using the Malay version of the BDI
may be prohibited. In the case of the Malay versions of
the BDI-II and DASS, the scales have only been validated
in specific samples (e.g., men with urological problems,
postpartum women, and infertile couples [10, 11]).
The Malay versions of the BDI, BDI-II, and DASS are
multidimensional scales. Specific items from these multi-
dimensional scales could not yield a theoretically sound
composite score [13], reducing their sensitivity in detect-
ing changes in depression severity [7]. Unlike the afore-
mentioned scales, the MADRS-S is characterized by a
single domain and has good sensitivity in detecting
changes in depression and in tracing differential effects
of drug on placebo/treatment groups [7]. To the best
our knowledge, the Malay version of the MADRS-S has
not yet been validated. Therefore, the purpose of this
study was to examine the psychometric properties of
the Malay version of the Montgomery-Åsberg Depres-
sion Rating Scale (MADRS-BM).
Methods
Study design
Stage 1: Early development of the MADRS-BM
We obtained permission from the original author of the
MADRS, Stuart M. Montgomery, for conducting this
study. A copy of permission letter was sent to the editor
of this journal. The scale was translated from English to
Malay in parallel by two bilingual clinical psychologists,
whereas a bilingual language expert performed the back-
translation. Discrepancies between the original version
and the back translation were resolved through discus-
sion and adjustments were made, where necessary. In
Stage 1, we finalized the initial version of the MADRS-
BM with an expert panel of psychiatrists and family
physicians.
Stage 2: Refinement of the MADRS-BM
We pilot-tested the initial version of the MADRS-BM
using 10 native Malay-speaking nurses to identify any
flaws in terms of wording. We noted any words that
were considered unsuitable or inappropriate. The scale
was also reviewed by a psychiatric consultant, who has
vast experience in clinical research, to ensure satisfac-
tory face, semantic, criterion, and conceptual equiva-
lences. In Stage 2, we redefined the Malay version of
the MADRS-BM.
Stage 3: Evaluation of the MADRS-BM
Participants and procedure
The study was conducted from September until December
2013 at Psychiatric Outpatient Clinic, University Malaya
Medical Centre. The study protocol was approved by the
Medical Ethics Committee (MEC) of the University
Malaya Medical Centre. For the purposes of the study,
we recruited individuals with and without depression.
Criteria to select individuals with depression include:
(a) subjects who were diagnosed with major depressive
disorder (the first author who is a trained clinical psych-
iatrist confirmed the diagnoses using the Diagnostic and
Statistical Manual of Mental Disorders, 4th Edition, Text
Revision (DSM-IV-TR [14]),(b) subjects who had no other
major psychiatric illnesses or psychoses, (c) subjects who
are capable of understanding and reading Malay or
English, (d) subjects who are 18 or above, and (e) sub-
jects who gave consent with regard to participation of
this study. Individuals without depression were medical
workers from the University Malaya Medical Centre.
Their participation was based on the criteria as indi-
cated above with the exception of (b). Based on subject
to ratios of 5:1, it is statistical appropriate to include 45
individuals with depression and 90 individuals without
depression, given that the MADRS-BM has nine items
[15]. However, to avoid attrition, we decided to recruit
50 individuals with depression and 100 individuals
without depression. For data collection, we identified
the eligible subjects and explained research procedure
to them. After we sought their written consent, we
then distributed a self-administered questionnaire. To
obtain test-retest reliability of the MADRS-BM, we




Participants were invited to provide their socio-demographic
information such as age, gender, ethnic group, marital status,
educational level, religion, and employment status.
The Malay version of the Beck Depression Inventory-Second
Edition (BDI-II-M)
The BDI-II-M is a 21-item self-report measure of depres-
sion based on a 2-week time period [11]. Participants
rated items based on a 4-point Likert Scale ranging
from 0 (no depressive symptoms) to 3 (worst depressive
symptoms). Higher scores indicate greater depression.
As demonstrated in previous study, the scale demonstrated
high internal consistency (alpha = 0.89) and split-half reli-
ability (unequal length Spearman Brown = 0.84) [11].
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The Malay version of the Snaith-Hamilton Pleasure Scale
(SHAPS-M)
The SHAPS-M is a 14-item self-report measure of he-
donic experience encompassing interest/pastimes, social
interaction, sensory experience, and food/drink. Partici-
pants rated items based on a 4-point Likert scale ranging
from 1 (definitely disagree) to 4 (definitely agree) [16].
Lower scores indicate greater hedonic experience. The
scale exhibited excellent internal consistency (alpha =
0.96), concurrent validity, and parallel form reliability
(ICC = 0.65) in previous study [17].
The Malay version of the General Health Questionnaire-12
(GHQ-12)
The Malay version of the GHQ-12 is a 12-item self-
report measure of current mental health. Participants
rated items based on a 4-point Likert scale ranging from
0 (always) to 3 (never) for positive items and ranging
from 3 (always) to 0 (never) for negative items. Higher
scores indicate greater symptom severity. As shown in
previous study, the scale has good internal consistency
(alpha = 0.85) [18].
The self-rated version of the Montgomery-Ǻsberg
Depression Rating Scale (MADRS-S)
The English version of the MADRS-S is a 9-item self-
report measure of depression. Participants rated items
on a 4-point Likert scale ranging from 0 (no depressive
symptoms) to 3 (worst depressive symptoms). Higher
scores indicate greater symptom severity. As demon-
strated in previous study, the scale has good parallel
form reliability (ICC = 0.78) and adequate reliability
(alpha = 0.84) [9].
The Malay version of the Montgomery-Ǻsberg Depression
Rating Scale (MADRS-BM)
The Malay version of the MADRS-BM is a 9-item self-
report measure of depression. Both the MADRS-BM
and the MADRS-S are identical in terms of scoring and
interpretation as mentioned above.
Statistical analyses
Data analyses were completed with the use of Statistical
Package for the Social Sciences version 20.0 (SPSS,
Chicago, IL, USA). Baseline characteristics pertaining to
participants were computed using descriptive statistics.
To establish dimensionality of the MADRS-BM, we per-
formed principal component analysis. We used Cronbach’s
alpha to provide an indication of internal consistency. We
also assessed the homogeneity of the scales by calculating
correlation coefficients between items and total scores,
if an item was deleted. To examine the parallel form re-
liability between the MADRS-BM and MADRS, and
the one week test-retest reliability of the MADRS-BM,
we calculated the ICCs. In establishing concurrent val-
idity, we examined correlations between the MADRS-
BM and other measures (BDI-II-M, GHQ-12, and
SHAPS-M) with Spearman’s test. To examine whether
individuals with and without depression would differ
significantly in terms of the MADRS-BM scores, we
performed analysis of covariance (ANCOVA), while
controlling for age, gender, ethnicity, , marital status,
and educational level. The optimal MADRS-BM cut
off score for individuals with depression was deter-
mined on the co-ordinate points as indicated in the
receiver operating characteristic (ROC) analysis; we
then obtained the rates of sensitivity and specificity
Results
Table 1 shows demographic information across partici-
pants with and without depression. We recruited 50
participants with depression (50 % male, 50 % female)
and 100 participants without depression (28 % male,
72 % female).
Dimensionality of the MADRS-BM
Bartlett’s test of sphericity was significant (p < .01) and
the Kaiser-Meyer-Olkin measure of sampling adequacy
for the MADRS-BM was 0.93, indicating that the sam-
pling adequacy was meritorious [19]. A single factor was
extracted using the principle component approach
(eigenvalue >1.00), which accounted for 61.3 % of the
total variance. Likewise, as indicated by the scree plot, a
single predominant factor was displayed. Taken together,
the MADRS-BM contained only a single construct meas-
uring individuals’ psychological state.
Reliability
The MADRS-BM exhibited good internal consistency
(alpha = 0.78). All the items had corrected item-total
correlations that were 0.7 or above. Removal of items, if
any, would not increase the alpha value (see Table 2).
The parallel form reliability between the MADRS-S and
the MADRS-BM was excellent (ICC = 0.98, p < .01). The
scale demonstrated good one-week test-retest reliability
(ICC = .88, p < .01).
Validity
The MADRS-BM was significantly and positively corre-
lated with the BDI-II-M (p < .01) and the GHQ (p < .01)
scores, but the scale was significantly and negatively cor-
related with the SHAPS-M (p < .01). Therefore concur-
rent validity of the MADRS-BM was established (see
Table 3).
After adjusting for age, gender, ethnicity, educational
level, and marital status, individuals with depression (M =
7.97, SD = 5.70) significantly reported higher MADRS-BM
scores than did individuals without depression (M = 1.51,
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SD = 1.39) (Table 4). Our findings found additional evi-
dence for concurrent validity of the MADRS-BM.
The area under the receiver operating characteristic
curve (i.e., the AUC) was 0.91 (95 % CI = 0.86-0.96). The
optimal cut-off score to distinguish individuals with de-
pression from individual without depression was ≥ 4 with
a sensitivity of 78 % and a specificity of 86 %.
Discussion
Our current findings show that the MADRS-BM has
good internal consistency with an alpha value of 0.70. This
result is comparable to the properties of the clinician-
rated MADRS (alpha = 0.70) [2]. Also comparable to the
original version of the MADRS, the MADRS-BM demon-
strated good parallel form reliability (ICC = 0.98) and one-
week test-retest reliability (ICC = 0.88) [9]. The present
findings reveal that the MADRS-BM is at least equivalent,
if not better, to the MADRS as an assessment tool for de-
pression. In terms of dimensionality, our findings revealed
a single factor that accounted a large proportion of the
variance in MADRS-BM. In line with previous studies, its
factor structure was similar to that of the MADRS [7, 9].
We also examined the concurrent validity of the the
MADRS-BM by linking the MADRS-BM with the BDI-
II-M, GHQ-12, and SHAPS-M. Positive correlations be-
tween the MADRS-BM, BDI-II-M, and GHQ and nega-
tive correlation between the MADRS-BM and SHAPS-M
provide initial evidence of MADRS-BM’s concurrent
validity. Additional evidence for concurrent validity of
the MADRS-BM was reported. After adjusting for some
socio-demographic information, individuals with depres-
sion significantly reported higher MADRS-BM scores
as compared to individuals without depression.
In this study, the cut off score for the MADRS-BM
was 4, which is lower than the recommended score of 5,
as suggested by the original MADRS. One possible
Table 2 Corrected item-total correlations and Cronbach’s alpha













Mood 7.02 75.55 0.79 0.75
Feelings
of unease
6.69 75.53 0.78 0.75
Sleep 6.68 78.25 0.57 0.76
Appetite 7.06 78.14 0.62 0.76
Ability to
concentrate
6.82 75.31 0.77 0.75
Initiative 6.87 75.55 0.80 0.75
Emotional
involvement
6.99 75.68 0.82 0.75
Pessimism 6.83 75.13 0.80 0.75
Zest for life 7.08 77.08 0.76 0.76
Total score 3.66 21.32 1.00 0.91
Note: MADRS-BM =Malay version of the Montgomery-Ǻsberg Depression
Rating Scale
Table 1 Socio-demographic characteristics
Variables Cases Total,







N = 100 (%)
Age
(mean ± SD)
47.16 ± 14.4 29.09 ± 10.53 35.11 ± 14.68 <.01
Gender <.05
Male 25 (50.0) 28 (28.0) 53 (35.3)
Female 25 (50.0) 72 (72.0) 97 (64.7)
Marital Status <.01
Single 13 (26.0) 64 (64.0) 77 (51.3)
Married 32 (64.0) 35 (35.0) 67 (44.7)
Divorced 1 (2.0) 1 (0.7)
Widowed 4 (8.0) 1 (1.0) 5 (3.3)
Ethnicity <.01
Malay 15 (30.0) 70 (70.0) 85 (56.7)
Chinese 20 (40.0) 23 (23.0) 43 (28.7)
Indian 12 (24.0) 7 (7.0) 19 (12.7)
Others 3 (6.0) 3 (2.0)
Religion <.01
Islam 16 (32.0) 71 (71.0) 87 (58.0)
Christianity 9 (18.0) 5 (5.0) 14 (9.3)
Buddhism 15 (30.0) 15 (15.0) 30 (20.0)
Hinduism 7 (14.0) 7 (7.0) 14 (9.3)
Others 3 (6.0) 2 (2.0) 5 (3.3)
Educational Level <.05
Primary 2 (4.0) 2 (1.3)
Secondary 19 (38.0) 21 (21.0) 40 (26.7)
Tertiary 29 (58.0) 79 (79.0) 108 (72)
Employment Status 0.941a
Employed 24 (48.0) 54 (54.0) 78 (52.0)
Unemployed 26 (52.0) 46 (46.0) 72 (48.0)
Note: aNot significant
Table 3 Spearman’s correlations (r) among the (MADRS-BM),
BDI-II, GHQ-12, and SHAPS-M
MADRS-BM BDI-II-M GHQ-12 SHAPS-M
MADRS-BM 1.000 0.779** 0.584** −0.398**
BDI-II 1.000 0.659** −0.393**
GHQ-12 1.000 −0.439**
SHAPS-M 1.000
Note: MADRS-BM =Malay version of the Montgomery-Ǻsberg Depression
Rating Scale; BDI-II = Beck Depression Index, second version; GHQ-12 = General
Health Questionnaire-12; SHAPS = Snaith-Hamilton Pleasure Scale.
*P < .05, **P < .01
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explanation is that the current version of the MADRS-
BM is a self-rated scale—participants tend to underrate
or underestimate their symptoms. Even though the cut
off score was lower than that of the MADRS, the
MADRS-BM’s sensitivity was greater than that of the
MADRS.
A few limitations of this study warrant consideration.
Firstly, given the cross-sectional nature of this study, we
were unable to rule out the causal factors of depression.
Likewise, we were unable to assess the predictive validity
of the MADRS-BM. Secondly, our sample was recruited
from an outpatient clinic in a tertiary hospital using
convenience sampling; thus we raised concern over
generalizability as one possible limitation. Lastly, some
clinical features such as the severity of depression and
the types of antidepressants being used by the patients
were not documented in the current study. The pres-
ence of such clinical features could affect the MADRS-
BM scores as reported by participants.
Conclusion
In spite of these limitations, the MADRS-BM demon-
strated promising psychometric properties in terms of di-
mensionality, reliability, and validity that generally justifies
its use in routine clinical practice in Malaysia. In order to
further establish its psychometric properties, future diag-
nostic studies using the standards for reporting of diag-
nostic accuracy (STARD) criteria are recommended.
Endnotes
This is a requirement for online studies made by the
local ethics committee.
Competing interests
The authors declare that they have no competing interests.
Author’s contributions
AY conceived the study and developed the study material. ARMY, AY, and
HMH conducted the forward and backward translations of the Montgomery–
Åsberg Depression Rating Scale. AY and NCG carried out data collection. AY,
HSL, KAT and NCG analysed the data, and AY, HSL, NCG, and HMH drafted the
manuscript. All authors read and approved the final manuscript.
Acknowledgements
This study was carried out at the University of Malaya Medical Centre, Kuala
Lumpur, Malaysia. We would like to extend our appreciation to Stuart M.
Montgomery for granting the permissions to translate the MADRS-S and to
publish the MADRS-BM. We would also like thank Danial Aziz Bahaman,
Helenna Hashim, and Ernie Azwa Yusop for conducting the forward and
backward translations of the MADRS-S.
Table 4 Comparison between individuals with and without depression with regard to the MADRS-BM total scores and item scores
The MADRS-BM The MADRS-BM mean scores Mean difference Adjusted mean differencea P value
Mean (SD) (95 % CI)
Case Control
Mood 0.83 0.45 0.78 0.68 <.001
(0.91) (0.23) (0.43, 0.92)
Feelings of unease 1.11 0.39 0.72 0.74 <.001
(0.79) (0.45) (0.48, 1.01)
Sleep 0.97 0.16 0.80 0.73 <.001
(0.80) (0.32) (0.49, 0.97)
Appetite 0.66 0.07 0.59 0.39 <.001
(0.90) (0.21) (0.16, 0.63)
Ability to concentrate 0.96 0.27 0.68 0.70 <.001
(0.87) (0.46) (0.42, 0.98)
Initiative 0.90 0.23 0.66 0.67 <.001
(0.84) (0.41) (0.42, 0.93)
Emotional involvement 0.88 0.05 0.82 0.83 <.001
(0.84) (0.19) (0.62, 1.04)
Pessimism 1.00 0.23 0.76 0.78 <.001
(0.86) (0.39) (0.52, 1.04)
Zest for life 0.66 0.04 0.62 0.65 <.001
(0.85) (0.16) (0.42, 0.87)
Total score 7.97 1.51 6.46 6.21 <.001
(5.70) (1.39) (4.71, 7.70)
Note: aadjusted for age, gender, ethnicity, educational level, and marital status
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